Nicotine dependence plays a critical role in addiction to tobacco products, and thus contributes to a variety of devastating tobacco-related diseases (SGR 2014). Annual costs associated with smoking in the US are estimated to be between $289 and $333 billion. Effective interventions for nicotine dependence, especially in smokers, are a critical barrier to the eradication of tobacco-related diseases. This overview highlights research presented at the Plenary Symposium of Behavior, Biology and Chemistry: Translational Research in Addiction Conference (BBC), hosted by the UT Health Science Center San Antonio, on March 9-10, 2013. The Plenary Symposium focused on tobacco addiction, and covered topics ranging from basic science to national policy. As in previous years, the meeting brought together globally-renowned scientists, graduate student recruits, and young scientists from underrepresented populations in Texas and other states with the goal of fostering interest in drug addiction research in young generations.
Bibliographical noteFunding Information:
This manuscript is based on a symposium given at the 2013 Behavior, Biology and Chemistry: Translational Research in Addiction meeting, which was supported in part by grant R13DA029347 from the National institute on Drug Abuse .
Work discussed in the manuscript was supported in part by the following NIH grants: DA017173 , DA024385 , U19CA148127 to MDB; U19DA017548 to PC, LPD & MTB; DA10714 to PP; U19CA157345 and U54DA03165 to DH. The NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
- Nicotine dependence
- Nicotine vaccine
- Nicotine withdrawal
- Nicotinic receptor antagonists
- Smoking cessation
- Tobacco product regulation